• News
  • SAN DIEGO
  • Finance

Otonomy raises $49M Series D

San Diego’s Otonomy Inc., a biopharmaceutical company developing and commercializing therapeutics for diseases and disorders of the inner and middle ear, secured $49 million in an oversubscribed Series D round of financing.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!